Integrating oncolytic viruses in combination cancer immunotherapy

@article{Bommareddy2018IntegratingOV,
  title={Integrating oncolytic viruses in combination cancer immunotherapy},
  author={Praveen K. Bommareddy and Megha Shettigar and Howard L. Kaufman},
  journal={Nature Reviews Immunology},
  year={2018},
  volume={18},
  pages={498-513}
}
Oncolytic viruses can be usefully integrated into tumour immunotherapies, as they target multiple steps within the cancer–immunity cycle. Oncolytic viruses directly lyse tumour cells, leading to the release of soluble antigens, danger signals and type I interferons, which drive antitumour immunity. In addition, some oncolytic viruses can be engineered to express therapeutic genes or can functionally alter tumour-associated endothelial cells, further enhancing T cell recruitment into immune… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

References

Publications referenced by this paper.
Showing 1-10 of 149 references

Oncolytic herpes simplex viruses as a paradigm for the treatment of cancer

P. K. Bommareddy, C. Peters, D. Saha, S. D. Rabkin, H. L. Kaufman
Annu. Rev. Cancer Biol • 2018

PDL1 in tumor microenvironment mediates resistance to oncolytic immunotherapy

D Zamarin
J. Clin. Invest • 2018

Similar Papers

Loading similar papers…